The Rise of the KP.2 Variant and Other Emerging COVID-19 Variants in 2024

The Rise of the KP.2 Variant and Other Emerging COVID-19 Variants in 2024 KP.2: The New Dominant Variant     

In April 2024, the KP.2 variant emerged as the dominant strain of COVID-19 in the United States, according to the Centers for Disease Control and Prevention (CDC). This variant, part of a group known as FLiRT, now accounts for approximately 25% of new COVID-19 cases, overtaking the previously dominant JN.1 variant, which comprises around 22% of recent infections (EverydayHealth.com) (HealthDay).

What Are FLiRT Variants?             

FLiRT variants, including KP.2, are defined by specific mutations in their spike proteins that enhance their ability to infect human cells and evade immune responses. These mutations have occurred independently in different viral lineages, resulting in similar characteristics despite separate evolutionary paths. The name FLiRT is derived from the technical names of these mutations (Home).

Impact on Vaccine Strategies

The emergence of FLiRT variants, particularly KP.2, has significant implications for vaccine strategies. The World Health Organization (WHO) recommended using the JN.1 lineage for future vaccines in late April. However, the rapid rise of KP.2 has led the US Food and Drug Administration (FDA) to delay its advisory committee meeting to June. This postponement is intended to allow more time to assess which variant will be most prevalent and potentially adjust the vaccine formulations to better target the dominant strain in the fall (HealthDay).

Symptoms and Public Health Response

The symptoms of the KP.2 variant are similar to those of other recent COVID-19 strains. Common symptoms include fever, cough, sore throat, congestion, muscle aches, and fatigue. While most individuals with prior vaccination or infection are protected against severe illness, there remains concern for those with weakened immune systems or underlying health conditions (EverydayHealth.com) (Yahoo).

Other Emerging Variants

In addition to KP.2, other FLiRT variants such as KP.1.1 are also gaining attention. KP.1.1 currently accounts for about 7% of new cases. Experts predict that FLiRT variants, due to their higher viral fitness, may become predominant worldwide. This situation underscores the need for continuous monitoring and adaptability in public health responses (EverydayHealth.com) (Home).

Expert Opinions

Dr. Megan Ranney, Dean of the Yale School of Public Health, has highlighted the need for vigilance as new variants continue to emerge. She stresses the importance of maintaining high vaccination rates and staying informed about new developments. Additionally, Dr. Eric Topol from the Scripps Research Translational Institute predicts a "wavelet" of infections due to FLiRT variants, although he does not foresee a significant new wave of infections (Home) (HealthDay).

The rise of the KP.2 variant and other FLiRT variants highlights the ongoing evolution of the COVID-19 virus and the necessity for adaptive public health strategies. As the situation develops, it remains crucial for the public to stay informed and for health authorities to adjust their approaches to vaccination and mitigation measures accordingly.

For more detailed information, please refer to sources such as the CDC, the WHO, and recent articles from HealthDay and Everyday Health.

Sources:

"New FLiRT COVID Variant KP.2 Becomes Dominant." Everyday Health. Link
"What to Know About the ‘FLiRT’ Variants of COVID-19." University of Nebraska Medical Center. Link
"There's a New Set of COVID Variants Called FLiRT: What You Need to Know." HealthDay.  Link
"These Are the 2 Most Common Symptoms of the New FLiRT COVID Variant Doctors Are Seeing Right Now." Yahoo News. Link

WNCTimes

Image Credit: WNCTimes